MRFF funding for personalised mRNA cancer vaccines

News - July 26, 2024

BASE scientists have been awarded funding from the Medical Research Future Fund (MRFF) to provide cancer researchers with access to personalised mRNA vaccine technologies. This funding will enable researchers to design mRNA cancer vaccines tailored to individual patients.

Back to news

Latest news from BASE

4th QLD mRNA Symposium

On International RNA Day (1 August), the BASE facility hosted the 4th QLD mRNA Symposium, bringing together leading experts from research, clinical, government, and industry to discuss advances in mRNA medicines.

Learn more

mRNA-LNP masterclass

Our graduates successfully completed the first Winter mRNA Masterclass, a week-long intensive program that trains students in the science, computational design, and laboratory production of mRNAs and LNPs.

Learn more

Our workflow published

We published our step-by-step protocol for mRNA-LNP production, describing the design, manufacture, and quality control of mRNA medicines using standard equipment in a research laboratory.

Learn more

Rapid mRNA Production

Over the past three years, we have established an end-to-end manufacturing work flow for the high-throughput production of mRNA-LNPs. Our advanced processes enable the rapid and reliable manufacture of high-quality mRNA-LNPs. These processes include cell-free DNA template production, automated liquid handling, and a quality management system.

Enquiries

Our team is available to help with your mRNA projects.